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Cryogenic1 zone compression GC-HRTOFMS for the
measurement of PCB-153 and DDE in 20 mL serum
samples
B. L'Homme and J.-F. Focant2
Human exposure to POPs is of concern and typical biomonitoring
studies require large amounts of blood (5–75mL) fromparticipants. As
a proof of concept, we developed a miniaturized method based on
MEPS and CZC applied to GC-HRTOFMS for the measurement of
markers of exposure (PCB-153, DDE) in 20 mL human serum samples.
Introduction
Humans all over the world are exposed to chemicals during
their lifetime. Among the thousands of existing anthropogenic
compounds are persistent organic pollutants (POPs), including
compounds like polychlorinated dibenzo-p-dioxins (PCDDs),
polychlorinated dibenzofurans (PCDFs), polychlorinated
biphenyls (PCBs), and organochlorine pesticides (OCPs), but
there are also a large number of newmolecules like halogenated
ame retardants (HFRs). Although the peak exposure to PCDD/
Fs, PCBs, and OCPs happened in the 1970's, their persistence
and ubiquity result, still today, in signicant exposure levels.
The aim of this work is to prove the concept of a minimally
invasive method for the analysis of selected POPs in a small
amount of sample (20 mL of serum). In this proof of concept
study we concentrated our eﬀorts on two target analytes (e.g.
PCB-153 and dichlorodiphenyldichloroethylene (DDE),
a metabolite of dichlorodiphenyltrichloroethane (DDT)) that
can be considered as representative markers of exposure for
both PCB and OCP families, and are of high interest in human
biomonitoring studies.1 Unlike the methodology recently
developed by Lu et al.,2 our method was based on the combi-
nation of a miniaturized sample preparation procedure named
micro-extraction by packed sorbent (MEPS) with the cryogenic
modulation of gas chromatographic peaks for signal enhance-
ment. This modulation process was reported earlier by Patter-
son et al.3 as cryogenic zone compression (CZC), a specic use of
comprehensive two-dimensional gas chromatography (GC !
GC) for ultra-trace level measurements. Similarly, fast GC is able
to improve compound detectability by time compression of
regular GC peak widths from a few dozens of seconds to a few
seconds,4 CZC is able to act as a refocusing device that reduces
GC peak widths to the 50–200 ms range. Modulated GC peaks
were characterized using a high-resolution (HR) mass spectro-
metric time-of-ight analyzer (TOFMS). We further show that
the method could easily be extended not only to other known
POPs (e.g. HFRs and PCDD/Fs), but also to more emerging
compounds thanks to the screening capabilities of GC ! GC.5,6
The use of (ultra) low volumes of blood can be an asset for
extensive human biomonitoring studies, and potentially
a valuable approach in the context of UNEP studies for POP
inventories,7 especially in remote areas or in regions of the
world, such as in central America,8 where the lack of data could
be, at least partly, overcome if an easy to use and non-invasive
sampling method was available. Furthermore the application
of the method to dried samples (dried-blood spots, DBSs),
a method developed by Guthrie in 1963,9 would facilitate long
range transportation and storage of such samples.10,11 To the
best of our knowledge, Dua et al. and Burse et al.were the rst to
briey report preliminary data on the potential use of human
DBSs for hexachlorocyclohexane (HCH), DDT, and DDE
measurement using GC coupled to a non-selective micro-
electron capture detector (mECD).12,13 POP measurements in
a small sample volume have also been investigated in 0.5 mL
plasma samples,14 in regular newborn screening program (NSP)
samples,1,15–17 and also in animal samples.18–20 Despite the fact
that these methods required a signicantly lower amount of
blood, compared to the typical amounts necessary in most
human biomonitoring studies (5–75 mL of serum21), they were
still requiring sample volumes of 100 mL or more, a quantity
hardly obtained by a simple nger or heel prick.
In this report, we present an analytical method that oﬀers
new possibilities with regards to the extremely low amount of
sample used, while maintaining adequate detection limits for
the measurement of 2 selected markers of exposure for both
PCB and OCP families. Next to CZC, the screening capabilities
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and HRTOFMS22 are also investigated for extension of the
approach to other POPs typically measured using classical GC




Samples used in this study were made of sub-samples origi-
nating from a measurement campaign that was run in our
ISO17025 routine laboratory. All details about samples are
available in a previous report.24 All experiments were performed
in compliance with the relevant laws and institutional guide-
lines; the research protocol was approved by the relevant insti-
tutional review boards and ethics committees (French Ministry
of Health, # 2001-1485). Written informed consent was obtained
from each participant before the interview. A single epidemi-
ologist collected data through a face-to-face interview. PCDD/F,
non dioxin-like PCB (NDL-PCB), as well as selected OCP refer-
ence levels were determined by a validated GC-IDHRMSmethod
following EU standards or food and feed under ISO 17025
regulation and used as reference values. A mixture of internal
standards of 13C-labeled DDE and 13C-labeled NDL-PCBs (#28,
52, 101, 138, 153, 180, and 209) (Cambridge Isotope Laborato-
ries (CIL), Andover, MS, USA) was used in all analyses for
isotopic dilution (ID) quantitation. Internal ID standards were
added to samples prior to extraction. The recovery standard was
made of a solution of 13C-labeled PCB-80 (CIL) and was added to
the cleaned extract just before the GC-MS injection. It was used
to assess the loss of compounds during analysis (internal
standard vs. recovery standard) and the quantitation was not
aﬀected by any loss of compounds since all analytes were
quantitated by ID against 13C-labeled internal standards. The
calibration curve of PCB-153 was constructed using EC-5179
and EC-4058 standard solutions (CIL). Solvents (formic acid,
methanol, hexane, dichloromethane and acetone) were
Picograde® reagents (LGC Promochem, Wesel, Germany). The
nonane puriss analytical-reagent grade standard for GC
was purchased from Fluka (Steinheim, Germany). Water was
obtained from a Milli-Q Ultrapure water purication system
(Millipore, Brussels, Belgium). Chromatographic pure grade
helium gas, 99.9999% alphagaz 2, was purchased from Air-
liquide (Paris, France).
Filter paper supports used for DBSs were provided by Perkin
Elmer (Norwalk, CT, USA). DBSs were prepared by pipetting
a nite amount of serum or blood on the paper and were then
dried in air for several hours and stored at room temperature in
zip-closing plastic bags. Samples were subsequently extracted
by liquid–liquid extraction (LLE) or by micro-extraction by
packed sorbent (MEPS) using a dedicated6 MEPS syringe and
C18 phase (SGE, Melbourne, Australia). LLE was performed
aer elution of the sample out of the paper with 150 mL phos-
phate buﬀer saline solution (PBS) followed by 150 mL formic
acid 98%. The LLE extraction solvent was a mixture of hexane/
dichloromethane (DCM) 70 : 30, and samples were extracted 3
times with 350 mL aer hand shaking and centrifugation at 4500
rpm for 5 min. Clean up aer LLE of 100 mL samples was carried
out as follows: a Pasteur pipette (230 mm) was lled with
approximately 2 g of acid silica (22% H2SO4) and 1 g of anhy-
drous sodium sulfate on the top. The hand-made column was
conditioned and samples were eluted with the same hexane/
DCM mixture. MEPS was carried out by loading the sample on
the sorbent (pumping several times), followed by washing with
400 mL water, and elution with hexane/DCM mixture 70 : 30.
Instrumentation
Measurements were carried out on a JEOL AccuTof T100GC
(JEOL Ltd., Tokyo, Japan). A GC oven (Agilent 6890) was
equipped with a ZX1 – liquid nitrogen dual stage cooled loop
modulator GC ! GC system (Zoex Corp., Houston, TX, USA).
The rst dimension (1D) GC column was an Rxi-XLB (30 m !
0.25 mm ID ! 0.25 mm df) (Restek Corp., Bellefonte, PA, USA).
The second dimension (2D) GC column was an Rxi-17 (1.5 m !
0.25 mm ID ! 0.25 mm df) (Restek). The oven temperature
program was 130 "C for 1 min, 10 "C min#1 to 238 "C, 2 "C
min#1 to 244 "C for 5 min, 2 "Cmin#1 to 268 "C, and 8 "Cmin#1
to 310 "C for 0.5 min. 1.5 mL of the nal extract in nonane (out of
5–10 mL) was injected into a split/splitless injector held at 250 "C
in splitless mode. Helium was used as the carrier gas at 1.0 mL
min#1. For negative chemical ionization (NCI) mode, MS
parameters were an ion source temperature of 140 "C, ionisa-
tion voltage of 70 eV, methane (reagent gas) at 1 mL min#1,
acquisition range from 30.00 to 400.00 m/z, a recording interval
of 0.04 s (25 Hz), an accumulation time of 0.037 s, a data
sampling interval of 0.5 ns, and a detector voltage of 2300 V. For
electron ionization (EI) mode, MS parameters were an ion
source temperature of 250 "C, ionization voltage of 70 eV,
a detector voltage of 2300 V and the same recording parameters
as with NCI. The mass accuracy of the instrument was ensured
by daily single point calibration checks. Two-dimension GC !
GC chromatograms were generated using GC Image soware
v2.3 (Zoex Corp.).
Cryogenic zone compression (CZC)
The cryogenic modulator was located between the two dimen-
sions to sequentially trap compounds coming out of 1D, refocus
them, and reintroduce them into 2D.25–27 Practically, one inter-
mittent hot jet and one permanent cold jet were focused on two
single points of the column (due to a loop), and the device was
reinjecting compounds in 2D when the hot jet was red. This
process produced peaks of 200 ms width by the time they
reached the mass spectrometer at the end of 2D. Because of
mass conservation, this zone compression process produced
narrower and higher peaks, resulting in the enhancement of the
overall sensitivity.28 Contrary to regular GC ! GC, where the
conservation rule29 implies the production of several slices for
each 1D signal to ensure proper resampling and possible reso-
lution of coeluting species, the CZC modulation process was
exclusively used for signal enhancement. Therefore, the
modulation period (PM, time between two hot jets, the duration
of a complete cycle of modulation) was enlarged from 4 to 8
seconds so that our 1D signals were only sampled once,


























resulting in the production of a single modulated slice, thus
increasing sensitivity as much as practically feasible (Fig. 1).
Results and discussion
Calibration curve
Calibration curves were obtained for DDE and for PCB-153. The
working dynamic range spanned from 50 fg to 10 pg. Six cali-
bration points (triplicates) gave a R2 of 0.99842 for PCB-153 and
0.96821 for DDE with RSD for all calibration levels below 15%
but with a constant lower precision for DDE, mainly due to the
weaker response and subsequent lower peak area for this
analyte.
Preparation of dried-blood spots (DBSs)
A nite and exact amount of serum or blood was pipetted to
a lter paper in order to ensure good control on the volume.
Transfer tips were never in direct contact with the paper. In this
way, the sample freely spread on the lter paper to warrant
constant volume delivery and to avoid oversaturating the lter
paper. Aer a drying period of 1 hour, the piece of paper was
subsequently cut around the dried sample. A blank of the same
size was always collected next to the sample to correct for
possible background levels.
Liquid–liquid extraction (LLE)
LLE was miniaturized and optimized to accommodate DBS
sample sizes. This is an easy-to-use method compatible with the
use of lter paper for dried samples, but diﬃcult to automate
due to the very small amount of solvents and samples handled.
The rst critical step was the choice of solvents for extraction.
For dilution and elution of the sample out of the lter paper,
a phosphate buﬀer saline solution (PBS) and formic acid were
used and a hexane/DCM mixture 70 : 30 was selected for the
extraction itself. The results from target analyte measurements
were cross-compared with regard to recovery rates and to bias
from the reference method results. This combination of
solvents gave a bias <$20% (RSD < 20%) and recovery rates
around 50%. The negative bias increased over 30% when
samples were not eluted out of the paper with formic acid. This
was therefore judged necessary to eﬀectively free target
molecules from encapsulation in lipidic structures, which are
known to be hydrolyzed by acid treatment.30 Diﬀerent sets of
hexane/DCM and hexane/acetone mixtures were further tested
for the LLE but conducted at lower recovery rates.
The optimization of the extraction step was carried out using
sample sizes of 100 mL and was then further transposed to
volumes down to 20 mL to reach the level of non-invasiveness
that was targeted. This was made by proportionally sizing
down volumes of aqueous and organic phases according to the
volume of serum collected on the lter paper. Therefore, 20 mL
samples required the use of 150 mL PBS and 150 mL formic acid
98% to elute the serum out of the paper, dilute it, denature
proteins, break down lipidic structures, and also partially
decompose the lter paper. At this stage, the emulsion con-
taining part of the lter paper always appeared and the addition
of a few drops of methanol was necessary to separate it and to
retrieve a liquid sample that could be properly extracted. The
manual extraction produced fractions that were collected
directly in a GC vial (1.2 mL) prior to full evaporation under
a nitrogen stream. The recovery standard and nonane, used as
keeper, were added just before injection. In total, less than
1.4 mL of solvents were used for the parallel extraction of 5
samples of 20 mL DBS in 3 h. Besides the fact that the method
cannot easily be automated, the major issue was that organic
and aqueous phases were diﬃcult to separate, even aer
centrifugation, preventing full recapture of solvents and there-
fore limiting recovery rates to the low 50% level. The scaling
down of the procedure to 20 mL sample sizes had also the
advantage to produce cleaner extracts than when using 100 mL
sample sizes. Despite the fact that the use of a disposable glass
micro-column was necessary to digest the remaining lipids and
keep the 100 mL sample extracts at an acceptable level of
cleanness, as is the case for regular sample sizes,31 20 mL sample
extracts were analyzed as such and the clean up step was not
necessary anymore, further simplifying the procedure.
A major issue in DBS analyses was to maintain the presence
of a suﬃcient quantity of analytes for their eﬃcient quanti-
cation. Indeed, as we reduced sample sizes, the diﬀerence
between blank levels and sample levels shrunk considerably.
This was actually the limitation in the miniaturization of the
DBS analysis, not to say that handling few microliters of
solvents was quite challenging. Samples were extracted in
Fig. 1 Adjustment of the modulation period (PM) to move frommultiple sampling (GC ! GC, left) to single sampling (CZC, right) of 1D signals for
maximal signal enhancement of target analytes.


























a routine accredited (ISO 17025) lab where dioxin, OCPs, PCBs
and other POPs are analyzed on a daily basis and where blank
levels are kept under control. The laboratory environment itself
appeared to have a greater inuence on background levels than
solvents and other consumables. Shaking and transfer steps of
the LLE procedure increased the contact between air and the
solution and were minimized as much as possible but remained
the major port of entry for external contaminants. For this LLE
approach, PCB-153 blank levels were in the range of 5–10 pg/
20 mL DBS, whereas typical background contamination levels
in DBS were in the range of 10–50 pg/20 mL. We therefore
reached the limit where blank levels were of the same order as
the sample levels. LLE-based measurements were performed
using paired sample-blank correction values instead of working
with themoving blank average quality control chart to be able to
quantify samples exhibiting the higher levels. This undesirable
situation could somewhat be improved by using a dedicated
clean-room for DBS measurements but such a room was not
available at the time of the study.
Micro-extraction by packed sorbent (MEPS)
As a ‘good method of extraction’ is easy to use, fast and robust,
automated, and cost eﬀective,32 we had to nd an alternative to
the LLE approach as it only fullled part of these criteria, and
especially suﬀered from blank issues. Another disadvantage of
the LLE procedure was that an operator was involved in many
steps, increasing risks of contamination and high variability. It
was furthermore diﬃcult to automate the procedure since it
required precise liquid handling, a similar situation to single-
drop micro-extraction (SDME),33 liquid-phase micro-extraction
(LPME),34,35 and electro-membrane extraction (EME).36–38 We
therefore investigated an alternative solid-phase extraction
(SPE)-based method, suitable for the analysis of our targets,39,40
and that allowed us to deal with small amounts of solvents and
samples. Micro-extraction by packed sorbent (MEPS) was per-
formed automatically on a automated liquid handler using
MEPS syringes.41 Practically, the sorbent (0.5–2 mg) was
included inside the needle of the syringe and was reused for up
to 10 times for diﬀerent samples before being replaced. Samples
were loaded on the sorbent aer elution out of the paper by
pumping the solution through the sorbent in the syringe (up to
50 times), and further eluted with the hexane/DCM mixture.
The sequence was developed and optimized during this study
and consisted of 6 steps, as illustrated in Fig. 2. All solvents were
similar to the ones used in LLE to keep parameters similar.
Internal standards were added on the lter paper aer it was
cut and before elution so that the organic solvent could evap-
orate. The organic phases collected (50 mL) aer the MEPS
sequence were collected in another vial and the solution was
evaporated until dryness and reconstituted with 3 mL recovery
standard and 2–5 mL of nonane to concentrate the extract as
much as possible. Nearly all the solution was injected (1–2 mL)
to ensure maximum response.
The method was optimized regarding loading, washing and
elution as dilution, and pre-soaking steps were identical to the
LLE method. One common parameter to optimize in each step
was the number of pump–release cycles of the syringe. For
loading, 50 times pumping was found to be the best since
pumping also mixed formic acid and serum, allowing the small
organic molecules to be encapsulated to reach the outer solvent.
It was also ideal to avoid clogging the MEPS cartridge with the
sample. Once loaded, the sorbent was washed 4 times with
water only. Methanol was also tested as a washing solvent,
based on previous experience,21 but recovery rates drastically
dropped (factor 5–10) due to a pre-elution of compounds in this
polar organic solvent. Finally, the elution was performed with
twice with 25 mL to minimize the volume of solvent used while
limiting the risk of carry over. Although the MEPS assembly is
designed to be used several times aer cleaning and condi-
tioning, a special care (washing at least 20 times with hexane)
was needed to prevent cross-contamination, which appeared to
be a weak point of the design. Ideally, to prevent carry over,
MEPS should be considered as disposable.
Samples were extracted within 20 minutes but this method
showed lower recovery rates than the LLE approach (15–30%).
However, cleaner chromatograms were observed due to the
lower amount of interfering compounds retained, and to amore
selective extraction. In addition, extractions were automated
and less subject to environmental contamination (lower back-
ground levels) than LLE since all solutions remained in capped
vials or in the MEPS syringe during the entire procedure.
Moreover, less transfer and no shaking steps were required. The
total volume of solvent required for the extraction was as low as
500 mL. For MEPS, blank levels were found to be in the range of
2–10 pg/20 mL DBS. Because of the use of 13C-based ID, the
impact of these limited recovery rates was limited to possible
compound detectability issues.
Cryogenic zone compression (CZC) GC and comprehensive
two-dimensional GC (GC ! GC) coupled to negative chemical
ionization high resolution time-of-ight mass spectrometry
(NCI-HRTOFMS)
CZC and GC ! GC were used to enhance chromatographic
signals and to increase the peak capacity of the chromatographic
Fig. 2 Cycling sequence for the use of MEPS syringes for the
extraction of selected POPmarkers of exposure in 20 mL human serum
samples.


























system prior to detection by using a mass analyzer.3,42 Despite
the fact that the number of target compounds was limited, the
use of two chromatographic dimensions (apolar phase as 1D and
semi-polar phase as 2D) was valuable to isolate matrix-related
interference away from the targets.43 The gain in intensity
following CZC was about 200 times between modulated and
non-modulated peaks at a 25 Hz acquisition rate, and still 10
times between modulated and non-modulated peaks at,
respectively, 25 Hz and 2 Hz, when 7 points data points7 were
consistently collected to properly dene peak shapes.44 The
instrumental limit of detection (iLOD) was assessed bymeans of
the signal to noise ratio (S/N) and was 20 fg mL#1 for PCB-153
(S/N ¼ 10), and 2 pg mL#1 for DDE (S/N ¼ 10), based on the
use of the M + 2 ion. On the other hand, we reached an iLOD of
40 fg mL#1 for DDE (S/N ¼ 10) when reconstructing traces based
on the chlorine ion signal. Monitoring the chlorine signal
instead of the M + 2 parent signal obviously precludes the use of
13C-labeled standards for quantitation and possibly reduces the
specicity of the qualication. It is however important to
remember that possible DDE coeluters have good chances to be
separated in 2D and that, in addition to the rst dimension
retention time value (1tR) and full mass spectra, a second
dimension retention time value (2tR) is available and brings an
extra clue for proper identication of DDE.45
Background levels in blood from individuals living in
industrialized countries can be very diﬀerent. Taking very
recent studies in Belgium46 and in Spain47,48 into account,
typical levels can be considered to be in the range of 50–100 ng
g#1 fat for PCB-153 and DDE. Based on a 20 mL DBS sample size,
we needed an iLOD at levels of 5–10 pg to properly quantify
those compounds. With iLODs achieved in this proof-of-
concept study, we are therefore able to quantify those targets
in such samples. More importantly, in the context of POP
inventories in developing countries where levels are somewhat
expected to be higher due to the lack of regulation, PCB-153 and
DDE would adequately be detected.
The HRTOFMS instrument was tuned to get the best
compromise between resolution and intensity. The intensity
was maximized while the mass resolution was maintained at
4000. As the targets of this study contained halogen atoms, we
decided to use the negative chemical ionization (NCI) mode,
a specic and sensitive ionization method for halogens.
Chemical ionization (used with methane as the reagent gas) is
a so ionization mode that prevents fragmentation by ther-
malizing electrons to lower their energy. A special yttria coated
rhenium lament was used to get a lower emission current as
well.49 As a result, fragmentation of halogen compounds was
very limited and parent molecular ions were maximized. This
provided, together with the zone compression by CZC, the best
sensitivity for the method. PCB-153 was quantitated on the
basis of the molecular ion and DDE was quantitated either on
the basis of the molecular ion or the chlorine ion. In this case,
DDE could be uniquely identied using the two retention times
provided by GC ! GC. The mass accuracy of the analyzer was
maintained at 5 ppm for all measurements.
Fig. 38 Two-dimensional GC ! GC contour plot (left) and one-dimensional CZC chromatographic traces (right) for a real unfortiﬁed 20 mL
human serum sample using NCI-HRTOFMS (TIC traces).
Fig. 4 Extraction of a molecular formula from the M + 2 signal of the parent ion cluster of CZC-NCI-HRTOFMS data collected from the MEPS of
the unfortiﬁed 20 mL human DBS sample.


























Additionally, based on the GC ! GC separation in a 2D
space, this approach is particularly suitable to enlarge the list of
targets to other POPs and further screen for unknown emerging
analytes that would be similarly isolated. Although for target
analysis we simply used the 1D reconstructed chromatographic
trace as we only got one slice of modulation per peak, a proper
GC ! GC investigation requires several slices to be produced
from each 1D signal. The modulation period (PM) was reduced
and the sensitivity was partly traded when this screening mode
was investigated. Reconstructed 2D representations were used
for screening and for pattern recognition (Fig. 3). In Fig. 3,
despite the apparent low amount of peaks, we identied other
dominant PCBs and separated some of them (PCB-80 and PCB-
101 for example) from interference thanks to the 2D. Data in
Fig. 3 were recorded in NCI mode, which provided a low back-
ground level and a more specic response to halogenated
compounds. In addition, our instrument allowed us to switch
easily, in about 20 minutes, between ionization modes. There-
fore, next to NCI also used together with CZC to maximize
sensitivity, we injected the same sample in electron ionization
(EI) mode at 70 eV to increase the fragmentation to perform
library searching and structural analysis. Specication of the
instrument was 5 ppm for mass accuracy, and 4000 for resolu-
tion. We had access to both the molecular formula and isotopic
pattern calculations. An example of the usefulness of the
HRTOFMS and the formula calculation is illustrated in Fig. 4,
where the full mass spectrum of an abundant peak in a real
20 mL DBS sample revealed another hexachlorinated PCB
(parent ion at 359.83871 Da). The proposed highlighted formula
is the rst possible formula of a native compound with regard to
the isotopic distribution of chlorine atoms. The mass accuracy
observed in this case was slightly lower (7.6 ppm) than the 5
ppm specication, likely due to the matrix eﬀect. The hyphen-
ation of GC ! GC to high resolution TOFMS was thus a really
powerful tool that was sensitive enough, thanks to the cryogenic
compression of signals, to analyze POPs in small sample
amounts (20 mL). It could easily be further complemented by
pre-screening data tools such as the one based on sentinel
ltration of MS signals using mass defects.50,51
Conclusion
These results demonstrate the feasibility of analyzing selected
POPs in a small sample amount (20 mL) such as human dried-
blood spots (DBSs). The sample preparation appeared to be
the crucial point in the procedure. Liquid–liquid extraction
(LLE) was rst developed with good success but micro-
extraction by packed sorbent (MEPS) was more suitable in our
quest for miniaturization. Indeed, the procedure was auto-
mated and only 500 mL of solvent were required for the whole
extraction. Our instrumentation, combining advantages of GC
! GC and CZC with negative chemical ionization (NCI), and
high resolution time-of-ight mass spectrometry (HRTOFMS),
provided a very sensitive and specic solution for the
measurement of selected POPmarkers of exposure in blood and
serum using isotopic dilution (ID). Target analysis was
demonstrated with PCB-153 and DDE, but screening
capabilities of the system arose and will make analyses of other
POPs, and unknown and/or emergent compounds possible in
the future.
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